National Comprehensive Cancer Network

Interactive CME

Educational Events & Programs

NCCN POLICY SUMMIT DATE  >  Monday, June 25, 2018 > Register!

NCCN POLICY SUMMIT LOCATION  > The National Press Club • Washington, DC



The summit will explore the impact of new innovations and the rapidly shifting health policy landscape on access to high-quality cancer care in the United States. Experts in the field will identify strategies to ensure access and affordability to innovation and novel therapies, review current policies under the direction of Food and Drug Administration (FDA) Commissioner Scott Gottlieb to make oversight more effective and efficient, and discuss recent healthcare regulations and legislation and their real world implications for oncology stakeholders.

Please check back often for additional updates regarding the summit. If you have any questions, please contact Alyssa Schatz, Director, Policy and Advocacy, U.S. and Global Development.


8:30 – 9:30 AM

Breakfast and Registration

9:30 – 9:40 AM

Welcome and Introductions

9:40 – 10:30 AM

Accelerating Access to Innovation

10:30 – 10:40 AM


10:40 AM – 12:00 PM

Panel Discussion – Paying for Innovation

12:00 –12:50 PM


12:50 – 1:10 PM

Network Adequacy in the ACA Exchange: Narrow Network Implications for Access to High Quality Academic Cancer Centers

1:10 – 2:30 PM

Panel Discussion –The Evolving Healthcare Landscape: Implications for Access to Quality Cancer Care

2:30 – 3:15 PM

Cancer Policy in 2018

3:15 PM  Wrap-up and Conclusions

*Subject to change.


Supported by Adaptive Biotechnologies. Supported by AmerisourceBergen. Supported by an educational donation provided by Amgen. Supported by Astellas. Supported by AstraZeneca through its NCCN Corporate Council Membership. Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc. Sponsored by Clovis Oncology, Inc. Sponsored by Dendreon. Supported by Eisai. Supported by EMD Serono, Inc. Supported by a non-restricted medical education grant from Gilead Sciences, Inc. Supported by HELSINN. Supported by Heron. Supported by Incyte Corporation. Supported by Janssen Pharmaceutical Companies of Johnson & Johnson. Supported by Juno Therapeutics. This activity is supported by a contribution from Lilly. Supported by an independent educational grant from Merck & Co., Inc. Sponsored by Novartis Pharmaceuticals Corporation. This activity was made possible by Pharmacyclics, an AbbVie Company and Janssen Biotech, Inc. Supported by Regeneron. Sponsored by Sandoz, A Novartis Division. Supported by an unrestricted sponsorship from TESARO. Supported by Verastem.

As of March 9, 2018

Access the Library of White Papers!

NCCN offers a broad library of white papers from previous summits that may be pertinent to your organization.

View Supporter Opportunities.

NCCN offers organizations various supporter opportunities.